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Objective: To investigate the antidiabetic activity of Ocimum tenuiﬂorum L. (O. tenui-
ﬂorum) leaves used in the traditional medicine management of diabetes in Malaysia.
Methods: O. tenuiﬂorum leaveswere extracted sequentially with hexane, chloroform, ethyl
acetate, methanol, and water. The extracts were evaluated in terms of antidiabetic activity by
using acute, subcutaneous glucose tolerance, and sub-chronic tests in streptozotocin-
induced diabetic rats. The extracts were also subjected to phytochemical analyses.
Results: With an acute dose (1 g/kg), the methanol extracts showed signiﬁcant reduction
(31%) in fasting blood glucose (FBG) of the streptozotocin-induced diabetic rats. The
FBG-decreasing effect of ethyl acetate extract was more rapid than that of the other
extracts; the decreasing rates were 20% after 2 h, 21% after 3 h, and 8% after 5 and 7 h.
After 7 h (31%), the effect of methanol extract on FBG was signiﬁcantly lower than that
of metformin. In the subcutaneous glucose tolerance test, only methanol and hexane
extracts showed the similarity of metformin in diabetic rats. After 14 days, the effects of
these extracts were similar to those of metformin (63.33%). The total ﬂavonoid and
phenolic contents of extracts decreased as the polarity of the extraction solvent increased.
Conclusions: The results obtained provide support for a possible use of O. tenuiﬂorum
leaves in managing hyperglycemia and preventing the complications associated with it in
type 2 diabetic.1. Introduction
Dietary substrates play a key role in physiological mechanisms
controlling intermediary metabolism and various abnormalities
in different human diseases, including cardiovascular and other
metabolic diseases, hyperlipidemia, thrombosis, hypertension,and diabetes [1]. Diabetes mellitus is caused by several
abnormalities in intermediary metabolism, such as dis-
arrangements in carbohydrates, proteins, and fat metabolism
resulting from the complete or relatively insufﬁcient insulin
secretion and activity [2]. Diabetes is categorized into two
types: types 1 and 2. Type 1 diabetes is also called insulin-
dependent diabetes mellitus. In this condition, the body does
not produce insulin; therefore, patients with type 1 diabetes must
receive daily insulin injections to remain alive. Type 1 diabetes
also accounts for 5%–10% of diabetes cases. Type 2 diabetes is
also known as non-insulin-dependent diabetes mellitus; in this
condition, the body does not produce enough amounts of insulin
or does not properly use this substance. Type 2 diabetes is the
most common type of this disease. In adults, this type of diabetic
accounts for about 90%–95% of all diagnosed. However, 9 out of
10 people of this group don't know that they have pre-diabetes
[3,4]. Reasons for this rise include the increase in sedentary
lifestyle, consumption of energy-rich diet, obesity, higher life
span, etc. [5]. Type 2 diabetes is widely distributed in Asia andarticle under the CC BY-NC-ND license (http://
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higher than the present rates [2]. Synthetic hypoglycemic agents and
insulin can produce serious side effects. They are also inappropriate
for use during pregnancy. As traditional medicine, plants represent
a valuable alternative to control and treat diabetes mellitus with
minimal or no side effects in clinical settings; plants also entail
relatively lower costs than oral synthetic hypoglycemic agents
[6,7]. According to ethnobotanical reports, approximately 800
plants may exhibit antidiabetic properties [8]. As such, many
plants have been recommended to treat diabetes [5,6]. The
principal chemical compounds isolated and identiﬁed from plants
are glycans, proteins, and mucilages. Other compounds, such as
phenolics, ﬂavonoids, steroids, triterpenoids, and alkaloids, with
hypoglycemic activity, have been extracted from traditional
medicinal plants by using different organic solvents [9]. Ocimum
sanctum (O. sanctum) as one of the main genus of Ocimum
(Lamiaceae) is medicinally used to treat diuresis, cardiopathy,
hemopathy, leucoderma, asthma, bronchitis, catarrhal fever,
otalgia, hepatopathy, lumbago, ophthalmia, and gastropathy in
children, as well as gastrointestinal disorders, ringworm,
verminosis, and skin diseases [10]. Previous studies indicated that
the hydroalcoholic and chloroform extracts of O. sanctum
aerial part are effectively used to treat diabetes. Hydroalcoholic
extracts are more potent than chloroform extracts [11]. Ocimum
tenuiﬂorum L. (Lamiaceae) (O. tenuiﬂorum), called “ruku” in
Malaysia, is usually cultivated as an ornamental plant because of
its yellowish ﬂowers.
In Malaysia, young O. tenuiﬂorum leaves are used to make
Nasi Ulam. O. tenuiﬂorum is classiﬁed as a herb because of its
medicinal properties [12]. Its leaves contain essential oil with
various compounds exhibiting medicinal values [13].
In India, plants are highly sacred because of their numerous
curative uses [12]. Notwithstanding the usage of this plant, it
has not been attending to make the study of the effects of
O. tenuiﬂorum leaves extract by non-polar to polar solvent with
antidiabetic potential. These studies were thus initiated with the
aim of evaluating the effect of n-hexane, chloroform, ethyl ace-
tate, and methanol and aqueous extracts of O. tenuiﬂorum leaves
on blood glucose level, short-term treatment, sub-chronic
toxicity, single oral glucose tolerance test, and the toxic effect
and measuring the total phenolics and total ﬂavonoids of different
crude extracts.
2. Materials and methods
2.1. Collection of plant materials
Fresh O. tenuiﬂorum (Lamiaceae) was collected in Perak,
Malaysia. A voucher specimen (Voucher No: 11400) was depos-
ited in the herbarium of the School of Biological Sciences, Uni-
versiti Sains Malaysia (USM). The leaves were separated from
stems and washed with tap water. Visibly damaged leaves were
removed, rinsedwith distilledwater, stripped, and freeze-dried for
3 days in a freeze dryer (Millrok Technology, LD53, Kingston,
USA), as described in a previous study [11,12]. The fully dried
O. tenuiﬂorum leaves were ground into powder by using a dry
blender (Panasonic, MX 335, Malaysia). The obtained leaf
powder was vacuum-packed and stored at 4 C (Toshiba, GR-
M48MP, Minato-ku, Japan) until further analysis [14].2.2. Preparation of plant extracts
The powdered leaves (200 g) were placed in an extraction
chamber and soaked in 800 mL of each of the non-polar and
polar solvents for 7 days at room temperature. The solvents were
then ﬁltered using Whatman No. 1 ﬁlter paper [15]. The ﬁltrate
was concentrated in vacuum in a rotary evaporator (EYELA,
N1200B, Ser: 1101348) at 30 C. The residue of the plant
material from the above was dried and re-extracted with next sol-
vent using the same procedure until the last solvent re-extracted.
2.3. Chemicals
As a standard anti-diabetic drug, metformin (500 mg/kg;
Glucophage®, Lipha Pharma Ltd., United Kingdom) was used as
positive control. Streptozotocin (STZ; Sigma–Aldrich Chemical
Co., USA) was used to induce diabetes. Other chemicals and
reagents were of analytical grade and were procured from
approved organizations.
2.4. Induction of diabetes
Diabetes was induced by intraperitoneally injecting 55 mg/kg
body weight of STZ (Sigma–Aldrich Chemical Co., USA) recon-
stituted in 0.1 mol/L cold citrate buffer (pH 4.5) after the rats were
subjected to fasting overnight. After 3 days of STZ administration,
glucose level wasmeasured in the blood collected from the tail vein
punctured by using an Accu-check Advantage II clinical glucose
meter (Roche Diagnostics Co., USA). In this study, the rats with
fasting blood glucose (FBG) > 15 mmol/L (270 mg/dL) were
considered diabetic and induced in the study. The percentage
change in blood glucose was calculated thus:
Percentage of glycemic change = (Gx − Gi)/Gx × 100
where Gx is the glycemia at time x and Gi is the glycemia at
initial time (i).
2.5. Experimental design
2.5.1. Animals
Male Sprague–Dawley rats weighing 250–300 g were pro-
cured from Animal Research and Service Center, USM. The rats
were kept in polypropylene cages under standard conditions:
(22 ± 3) C and a 12 h/12 h light/dark cycle. The rats were fed
with a commercial diet (Gold Moher, Lipton India Ltd.) and
allowed free access to water ad libitum. All experimental pro-
cedures involving animals were conducted in accordance with
the guidelines for the care and use of laboratory animals, as
approved by the Animal Ethical Committee, USM, Penang,
Malaysia [USM/Animal Ethics Approval/2013/(89) (479) and
Animal Research and Service Center, USM (Main Campus)].
2.5.2. Assessment of acute/single dose glucose response
test in non-diabetic and STZ–induced diabetic rats
The rats were divided into fourteen groups. Each group con-
tained six rats. Groups 1 and 2 were treated as normal positive and
negative control, respectively; Groups 3, 4, 5, 6, and 7 were nor-
mally treated with 1 g/kg body weight of chloroform, n-hexane,
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leaves, respectively; Groups 8 and 9 were treated as diabetic pos-
itive and negative control, respectively; Groups 10, 11, 12, 13, and
14 were treated with 1 g/kg body weight of chloroform, n-hexane,
ethyl acetate, methanol, and water extracts of O. tenuiﬂorum
leaves, respectively. Oral hypoglycemic agents were dissolved in
distilled water. Negative and positive normal rats and diabetic
control rats were fed with 10 mL/kg body weight of 1% carbox-
ymethyl cellulose (vehicle) and 500 mg/kg body weight of met-
formin. After the rats fasted overnight, the plant extract suspended
in distilled water was fed to the rats through gastric intubation by
using a force-feeding needle. Blood samples were then collected to
measure bloodglucose level from the tail vein at 0min and at 1, 2, 3,
5, and 7 h after the plant extracts were administered; blood glucose
levels were determined [14].2.5.3. Assessment of subcutaneous glucose tolerance test
(SGTT) in normal rats
The overnight fasted normal rats were divided into seven
groups, with six rats in each group. They were orally administered
with 1 g/kg body weight of vehicle, chloroform, n-hexane, ethyl
acetate, methanol, and water extracts of O. tenuiﬂorum leaves and
with 500 mg/kg body weight of metformin. Glucose (50 mg/kg
body weight) was fed within 30 min after the extracts were
administered [16]. Bloodwas taken through the tail vein at 0, 30, 60,
and 120 min of glucose administration; glucose levels were
measured by using a glucometer (Roche Diagnostics Co., USA).
2.5.4. Assessment of SGTT in STZ-induced diabetic rats
In this test, the procedure including doses of extraction used,
animal grouping, duration and glucose measurement and glucose
loading was the same in the section above, except animal grouping
that was considered as STZ-induced diabetic rats and control
groups as well.2.5.5. Assessment of the daily treatment of O. tenuiﬂorum
leaf extracts on STZ-induced diabetic rats
The rats were divided into fourteen groups; seven groups
with six rats in each group were used as normal treatment and
seven groups with six rats in each group were set as diabetic
treatment. Groups 1 and 2 were treated as normal positive and
negative control, respectively; Groups 3, 4, 5, 6, and 7 were
normally treated with 1 g/kg body weight of chloroform, n-hexane,
ethyl acetate, methanol, and water extracts of O. tenuiﬂorum
leaves, respectively; Groups 8 and 9 were treated as diabetic
positive and negative control, respectively; Groups 10, 11, 12,
13, and 14 were treated daily with 1 g/kg body weight of
chloroform, n-hexane, ethyl acetate, methanol, and water ex-
tracts of O. tenuiﬂorum leaves for fourteen days, respectively.
FBG levels were determined on Days 0, 7, and 14 of the treat-
ment. The body weight was monitored daily [14,17].2.6. Phytochemical analysis of the crude O. tenuiﬂorum
extracts
2.6.1. Determination of the total phenolic content
The total phenolic contents of the ﬁve different extracts of
O. tenuiﬂorum leavesprepared throughmacerationweredeterminedusing Folin–Ciocalteu reagent method. In brief, 0.4 mL (1 mg/mL)
of each extract was pipetted into a test tube, and 2 mL of (10% v/v)
Folin–Ciocalteu reagent was added to the extract sample. After
5 min, 1.6 mL of (7.5%) sodium carbonate solution was added to
the sample. The sample was then incubated for 1 h at room tem-
perature. Absorbance was detected using a Perkins Elmer UV–
visible spectrometer (USA) at 760 nm. A series of standard gallic
acid solutions (20–200 mg/mL) was prepared. Absorbance was
obtained at the same wavelength, and data were used to plot the
calibration curve. The total phenolic content was calculated as mg/
mL of the gallic acid equivalent of the extracts [18]. All of the
samples were analyzed in triplicate.2.6.2. Determination of the total ﬂavonoid contents
The total ﬂavonoid contents of the ﬁve different extracts of
O. tenuiﬂorum leaves prepared through maceration were deter-
mined using an aluminum chloride colorimetric method [19]. In
brief, 1.5 mL of the extract solution in the test tube was mixed
with 1.5 mL of 2% aluminum chloride solution prepared in
methanol. Absorbance was determined at 415 nm after the
extract solution was incubated for 10 min at room temperature
by using a double-beam Perkins Elmer UV–visible spectropho-
tometer (USA). The ﬂavonoid content of the extracts was calcu-
lated in mg/mL as quercetin equivalent by using an equation
obtained from the quercetin calibration curve. The calibration
curve was constructed using six different concentrations (3.125–
100.000 mg/mL) of the quercetin solution prepared in methanol.
All of the samples were analyzed in triplicate.2.7. Statistical analysis
Values were represented as mean ± SEM. Data were statis-
tically analyzed with One-way ANOVA followed by Dunnett's
honestly signiﬁcant difference (HSD) test by using GraphPad
Prism (version 6). P value < 0.05 was considered signiﬁcant [15].3. Results
3.1. Effect of the acute/single oral administration of
extracts/metformin on normal and STZ-induced diabetic
rats
The administration of 1 g/kg of hexane, ethyl acetate, and
methanol extracts of O. tenuiﬂorum leaves showed 5%, 10%,
and 13% decrease in blood glucose level 7 h after the treatment
(Table 1). This decrease was also signiﬁcantly lower than that
observed in the normal control group (P < 0.001). Chloroform
and aqueous extracts respectively increased the blood glucose
level by 41% and 12% during observation. Therefore, the hex-
ane and aqueous extract treatments in this test signiﬁcantly
increased the blood glucose level of the normal rats at the
administered dose of 1 g/kg body weight (P < 0.001). The ef-
fects of the extracts on the diabetic rats were more remarkable
(Table 2) than those on the diabetic control rats. The hexane
extract signiﬁcantly increased the blood glucose level by 15%
and 8% (P < 0.001) after 5 h and 7 h consequently. The ethyl
acetate extract induced an 8% decrease in blood glucose level
relative to that observed in the control group after 7 h.
Table 2
Effect of a single/acute dose of extracts/metformin on blood glucose of STZ-induced diabetic rats.
Treatment groups Baseline FBG 1 h 2 h 3 h 5 h 7 h
Control 23.6 ± 0.4 21.3 ± 9.0 22.3 ± 4.0a 27.8 ± 3.3 25.1 ± 2.6 21.2 ± 2.5
Hexane 26.0 ± 4.0 33.5 ± 0.5 31.0 ± 2.2a 30.0 ± 2.0 (15%) 30.0 ± 2.0a (15%) 28.1 ± 2.0a (8%)
Chloroform 32.0 ± 1.1 31.0 ± 4.0 31.0 ± 3.0a 29.0 ± 2.0 (9%) 28.0 ± 1.2c (12%) 27.0 ± 1.3a (16%)
Ethyl acetate 24.0 ± 4.0 31.0 ± 4.0 29.0 ± 2.0a (20%) 29.0 ± 1.3 (21%) 26.0 ± 1.1 (8%) 22.0 ± 2.4 (8%)
Methanol 26.0 ± 4.4 29.5 ± 1.0 29.0 ± 1.1a (11%) 25.0 ± 1.2 (4%) 23.0 ± 1.5 (11%) 18.0 ± 2.0b (31%)
Aqueous 31.0 ± 2.0 28.0 ± 6.0 28.0 ± 2.5a 28.0 ± 1.3 (10%) 28.0 ± 1.3c (10%) 26.0 ± 1.4a (16%)
Metformin 22.2 ± 1.7 18.0 ± 2.1 15.0 ± 0.15a (32%) 12.5 ± 1.3 (44%) 10.1 ± 0.7 (55%) 8.7 ± 0.3a (61%)
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c: P < 0.05 between diabetic treated groups and negative control as healthy
control groups (analyzed by One-way ANOVA Dunnett's HSD test). Percentage in bracket showed the amount of decreasing or increasing of the level
of blood glucose regarding to baseline of FBG.
Table 1
Effect of a single/acute dose of extracts/metformin on blood glucose of non-diabetic rats.
Treatment groups Baseline FBG 1 h 2 h 3 h 5 h 7 h
Control 6.4 ± 0.7 6.5 ± 0.4 7.3 ± 0.6 6.0 ± 0.6 8.0 ± 0.4 9.2 ± 0.6
Hexane 6.3 ± 0.1 7.0 ± 0.1 6.0 ± 0.2 6.5 ± 0.4 6.4 ± 0.3b (2%) 6.0 ± 0.4a (5%)
Chloroform 5.3 ± 1.2 10.0 ± 2.3 11.0 ± 2.0a 8.2 ± 1.3a 9.0 ± 1.2 (70%) 7.5 ± 1.2a (41%)
Ethyl acetate 7.0 ± 0.3 7.5 ± 0.4 8.0 ± 0.6 7.0 ± 0.3 6.3 ± 0.4a 6.3 ± 0.6a (10%)
Methanol 6.0 ± 0.1 6.0 ± 0.6 6.0 ± 0.6b 6.0 ± 0.2 6.0 ± 0.3a 5.2 ± 0.2a (13%)
Aqueous 8.0 ± 0.1 9.5 ± 0.3 10.0 ± 0.2a 9.0 ± 0.3a 9.0 ± 0.5 9.0 ± 0.4a (12%)
Metformin 7.6 ± 1.2 6.7 ± 0.4 6.0 ± 0.5c 5.0 ± 0.5 6.5 ± 0.6a (15%) 5.0 ± 0.6a (35%)
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c: P < 0.05 between diabetic treated groups and negative control as healthy
control groups (analyzed by One-way ANOVA Dunnett's HSD test). Percentage in bracket showed the amount of decreasing or increasing of the level
of blood glucose regarding to baseline of FBG.
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pattern. In particular, these extracts decreased the blood glucose
level by 16% after 7 h. The effect of the methanol extract was
very different. In particular, the methanol extract signiﬁcantly
decreased the blood glucose level by 31% after 7 h (P < 0.01)
relative to its effect on the diabetic control rats. This effect was
similar to that of metformin. Among the extracts used in this
study, the methanol extract was the most effective.
3.2. Effect of extracts/metformin on the SGTT of normal
and STZ-induced diabetic rats
Table 3 shows the effect of extracts on blood glucose of non-
diabetic rats after subcutaneous glucose load. Compared to the
control, drug administration and the hexane, chloroform, meth-
anol and aqueous extracts signiﬁcantly suppressed the peak blood
glucose after 15 min (P < 0.001) while ethyl acetate extract at the
same time displayed the signiﬁcance (P < 0.01) compared to
control. However, only chloroform extract showed signiﬁcant
(P < 0.01) decrease until the 90th min. While other extracts
showed signiﬁcance at the same level (P < 0.001). Table 4 shows
the effect of extracts of leaves of O. tenuiﬂorum and metforminTable 3
Effect of the extracts/metformin on blood glucose level after subcutaneous l
Treatment groups 0 min 15 min 30 min
Control 6.4 ± 0.2 10.0 ± 1.2 7.0 ± 0.3
Metformin 6.2 ± 0.7 6.3 ± 0.1a 7.0 ± 0.1
Hexane 7.0 ± 0.2 9.2 ± 1.2 8.0 ± 0.4
Chloroform 7.0 ± 0.6 15.1 ± 0.9a 15.1 ± 0.5
Ethyl acetate 7.0 ± 0.1 8.0 ± 1.0b 8.4 ± 0.1
Methanol 7.0 ± 0.1 7.0 ± 0.4a 8.5 ± 0.4
Aqueous 7.2 ± 0.8 7.0 ± 0.1a 9.0 ± 0.1
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c:
control groups (analyzed by One-way ANOVA Dunnett's HSD test).on SGTT. The hexane extract exerted signiﬁcant effect on blood
glucose at the 90th min until the 120th min (P < 0.05) compared
to control group at the same time. Whereas the other extracts
except hexane extract did not show any signiﬁcant effects during
the study. Metformin demonstrated a signiﬁcant effect all the
time, with the higher reduction in glucose level compared to
treatment groups with crude extracts (P < 0.05).
3.3. Effect of extracts/metformin on the body weight and
blood glucose of STZ-induced diabetic rats
Table 5 lists the changes in the body weight of the control
and experimental rats treated with the extracts and metformin.
The body weight (4.13%) of the STZ-induced diabetic rats was
signiﬁcantly lower than that of the normal control groups after
14 days. In addition, 14 daily administrations of ethyl acetate,
aqueous, and methanol extracts (1 g/kg) decreased the body
weight by 22.09%, 14.87%, and 7.52%, respectively. Further-
more, the daily administration of the extracts for 14 days caused
a signiﬁcant reduction compared with the diabetic control group
(Table 6). Almost the test extracts showed a signiﬁcant reduction
in blood glucose level at Day 14 except aqueous extract. Theoading of 50 mg/kg glucose in non-diabetic rats.
45 min 60 min 90 min 120 min
7.0 ± 0.4 8.5 ± 0.1 6.0 ± 0.9 7.0 ± 0.5
6.1 ± 0.7 7.3 ± 0.2c 7.0 ± 0.1a 6.2 ± 0.1
8.0 ± 0.3b 9.0 ± 0.3 8.0 ± 0.4a 7.0 ± 0.5
11.0 ± 0.4a 9.0 ± 1.2 6.4 ± 0.7b 8.0 ± 1.5
10.2 ± 0.7a 8.4 ± 0.4 6.3 ± 0.3a 7.0 ± 0.2
9.0 ± 0.4a 8.2 ± 1.0 7.0 ± 0.0a 6.5 ± 0.5
8.2 ± 0.4a 8.0 ± 0.1 9.0 ± 0.1a 9.0 ± 0.2a
P < 0.05 between diabetic treated groups and negative control as healthy
98.21
105.36
130.26
144.13
140
120
100 (μ
g/
m
L)
Table 5
Effect of oral administration of extracts (1 g/kg) or metformin (500 mg/kg) on body weight (g) of STZ-induced diabetic rats.
Treatment groups Day 0 Day 7 Day 14
Normal control 268.10 ± 30.40 255.50 ± 18.40 (+4.7%) 284.00 ± 14.80c (+5.93%)
Diabetic control 266.00 ± 15.50 234.00 ± 4.40 (−11.9%) 225.00 ± 8.40 (−4.13%)
Hexane 246.00 ± 52.33 216.33 ± 4.72 (−12.06%) –
Chloroform 270.00 ± 39.22 254.20 ± 47.01 (−5.85%) 274.00 ± 41.90c (+1.48%)
Ethyl acetate 253.20 ± 7.62 207.00 ± 14.31 (−18.24%) 197.25 ± 9.00 (−22.09%)
Methanol 241.50 ± 22.43 228.33 ± 37.23 (−5.45%) 223.33 ± 40.76 (−7.52%)
Aqueous 260.00 ± 20.60 243.66 ± 24.11 (−6.28%) 221.33 ± 26.50 (−14.87%)
Metformin 266.50 ± 13.30 278.00 ± 1.60c (+4.31%) 267.70 ± 2.73c (+0.45%)
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c: P < 0.05 between diabetic treated groups and negative control as healthy
control groups (analyzed by One-way ANOVA Dunnett's HSD test). − and + before the number of percentage, it means decrease and increase of the
level of weight and blood glucose compared to the baseline.
Table 6
Effect of daily oral administration of extracts (1 g/kg) or metformin (500 mg/kg) on blood glucose level of STZ-induced diabetic rats.
Treatment groups Day 0 Day 7 Day 14
Normal control 6.33 ± 0.60 5.00 ± 0.24 6.23 ± 0.16 (−1.57%)
Diabetic control 20.40 ± 1.31 22.03 ± 0.70 26.50 ± 1.50 (+29.9%)
Hexane 24.85 ± 3.70 22.75 ± 1.20 –
Chloroform 31.20 ± 1.08c 28.02 ± 8.50b 17.00 ± 13.30 (−45.51%)
Ethyl acetate 24.30 ± 2.50 19.45 ± 10.50 11.10 ± 2.50 (−54.32%)
Methanol 30.73 ± 1.00 14.40 ± 0.92c
(−53.14%)
11.00 ± 1.08a (−64.2%)
Aqueous 21.50 ± 9.50 23.00 ± 5.20 24.00 ± 7.00 (+11.62%)
Metformin 19.50 ± 6.50 12.10 ± 2.40 7.15 ± 0.30 (−63.33%)
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c: P < 0.05 between diabetic treated groups and negative control as healthy
control groups (analyzed by One-way ANOVA Dunnett's HSD test). − and + before the number of percentage, it means decrease and increase of the
level of weight and blood glucose compared to the baseline.
Table 4
Effect of the extracts/metformin on blood glucose level after subcutaneous loading in STZ-induced diabetic rats.
Treatment groups 0 min 15 min 30 min 45 min 60 min 90 min 120 min
Control 26.9 ± 5.0 25.5 ± 11.3 28.2 ± 3.3 22.4 ± 10.0 25.5 ± 4.5 28.1 ± 3.5 30.5 ± 1.3
Metformin 17.5 ± 2.1 21.0 ± 2.5 19.0 ± 3.1b 17.0 ± 3.0 17.0 ± 3.0b 14.1 ± 3.0b 16.4 ± 3.6c
Hexane 28.0 ± 6.1 27.0 ± 3.1 27.0 ± 2.0 27.3 ± 3.0 26.0 ± 2.1 24.1 ± 2.3c 24.2 ± 5.4c
Chloroform 24.0 ± 6.1 28.0 ± 6.0 29.5 ± 3.0 26.3 ± 2.4 27.5 ± 2.4 27.5 ± 2.1 25.0 ± 6.0
Ethyl acetate 26.0 ± 3.2 28.0 ± 3.0 28.0 ± 2.3 29.0 ± 3.0 28.0 ± 2.4 26.0 ± 2.3 29.0 ± 1.1
Methanol 29.4 ± 3.0 30.0 ± 0.7 29.4 ± 0.9 28.0 ± 1.2 28.0 ± 1.2 28.0 ± 1.1 28.0 ± 4.4
Aqueous 30.0 ± 2.0 30.0 ± 1.2 29.0 ± 1.3 28.0 ± 0.1 30.0 ± 0.1c 30.0 ± 1.2 31.5 ± 1.2
Values are expressed as mean ± SD (n = 6). a: P < 0.001, b: P < 0.01 and c: P < 0.05 between diabetic treated groups and negative control as healthy
control groups (analyzed by One-way ANOVA Dunnett's HSD test).
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roform (64.20%, 54.32% and 45.51%, respectively) (Table 6).
Hence, the methanol extract was also considered the most effec-
tive in anti-hyperglycemic effect.  Hexane         Chloroform    Ethyl acetate    Methanol      Aqueous
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Figure 1. Total phenolic content of O. tenuiﬂorum leaves extract (n = 3).3.4. Total phenolics in O. tenuiﬂorum extracts
Figure 1 illustrates the total phenolic contents of the different
extracts obtained through maceration. The hexane extract con-
tained less phenolic compounds, with (72.47 ± 0.30) mg/mL
gallic acid equivalent. The aqueous extract contained the highest
total phenolic compounds [(144.13 ± 0.15) mg/mL], followed by
the phenolic contents of methanol, ethyl acetate, and chloroform
extracts.3.5. Total ﬂavonoids in O. tenuiﬂorum extracts
The total ﬂavonoid contents of the different extracts of O. tenui-
ﬂorum leaves are shown as follows. The ethyl acetate extract yieldedthe highest total ﬂavonoid content, with (38.56 ± 0.41) mg/mL
quercetin equivalent. The aqueous extract [(27.74 ± 0.02) mg/mL]
and the methanol extract [(30.26 ±0.01) mg/mL] contained lower
totalﬂavonoid contents.Hexane andchloroformextracts alsoyielded
similar amounts of total ﬂavonoid contents [(31.76 ± 0.01) mg/mL].
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Various in vivo models, such as diazoxide, alloxan, or STZ-
induced diabetic rats, have been traditionally used to evaluate
medicinal plants with suspected hypoglycemic potentials.
In this study, diabetes mellitus was induced by intraperito-
neal injection of STZ at single dose of 55 mg/kg body weight in
rats. This dose reliably induced diabetes mellitus in the treated
rats 7 days post incubation. This result is consistent with that
described in previous studies on the treated rats with STZ-
induced hyperglycemia 5–7 days after intraperitoneal injection
[20]. Our study demonstrated that the minimum hyperglycemic
dose was 1 mg/kg body weight of the rats in all of the extracts.
This ﬁnding is consistent with that observed in a previous
study [21]. Using this diabetic model, we screened serial non-
polar to polar O. tenuiﬂorum extracts to determine their hy-
poglycemic and anti-hyperglycemic effects. The glucose-
lowering test in normal rats aimed to evaluate the tendency
of an extract/drug to produce hypoglycemia or side effects of
some anti-diabetic drugs. The glucose-lowering test in diabetic
rats aimed to examine the anti-diabetic property of an extract/
drug. In this study, O. tenuiﬂorum extracts did not signiﬁ-
cantly affect FBG at an acute dose of 1 g/kg until 2 h; after
7 h, these extracts signiﬁcantly decreased FBG (P < 0.0001).
This feature is desirable because hypoglycemia, a side effect
of most oral hypoglycemic agents, can lead to seizures and
even death; in other cases, hypoglycemia induces permanent
brain damage. The response to acute dose of glucose of the
diabetic rats indicated that all of the ﬁve extracts of
O. tenuiﬂorum decreased FBG at some points within 7 h. The
methanol extract induced reduction of FBG until 7 h to a
greater extent than metformin did. This ﬁnding suggested that
the methanol extract combination may be used to isolate the
active anti-diabetic compound in O. tenuiﬂorum. Therefore,
the methanol extract could be considered as a good candidate
to develop novel anti-diabetic natural products or standardized
herbal formulation. O. tenuiﬂorum extracts were also evaluated
to determine the inﬂuence on the tolerance level of parenteral
glucose administration in non-diabetic and diabetic rats. In this
model, glucose loading was administered subcutaneously
rather than orally to prevent the possibility of a false positive
response that could result from delayed glucose absorption
because of its interaction with sticky or waxy components and
various extracts, especially hexane and chloroform extracts.
However, the extracts except hexane signiﬁcantly retained the
same blood glucose level in the normal rats within 15–90 min
of glucose loading. This effect in SGTT test was also repli-
cated in the STZ-induced diabetic rats.
In our study, 1 g/kg of O. tenuiﬂorum extracts was admin-
istered daily to STZ-induced diabetic rats for 14 days. Body
weight and blood glucose were monitored within 14 days of
treatment. The body weight of the diabetic control rats was
lower than that of the normal control rats. Body weight gain is
an indicator of efﬁcient glucose homeostasis. Other alternative
fats and tissue proteins are broken down to produce energy ac-
counting for the loss in body weight [22]. Of the ﬁve treatments
in our study, the methanol extract induced a signiﬁcant recovery
in body weight after 7 and 14 days of treatment compared with
that observed in the diabetic control rats. This result indicated
improvement in insulin secretion, and control of glycemic
levels [14,15,23].All of the extracts except the aqueous extract signiﬁcantly
reduced the blood glucose levels of the diabetic rats 14 days
after the treatment. All of the diabetic rats treated with the
hexane extract died 1 day before sacriﬁced date on Day 13. By
contrast, the normal rats treated with the same dose of the
hexane extract survived until the last day of treatment. In
additional result, the body weight of rats showed reduction be-
tween 7 and 14 days after treatment.
However, among the extracts, the methanol extract induced
the highest decrease on blood glucose level at Days 7 (53.14%)
and 14 (64.20%). This decrease was almost greater than that
induced by metformin. The polarity of methanol is 5.1 compared
with that of other solvents characterized by moderate polarity.
Therefore, regarding this result it is expected that the extracts
with a moderate concentration of active compounds elicit anti-
hyperglycemic effects compared with high and low polarity
concentration of active compound that extracted by other sol-
vents. The present study also supports most of previous reports
that polar leaves extract can decrease blood glucose level [22,24].
Phenolic compounds, such as ﬂavonoids, phenolic acids, and
tannins are considered as major contributors to the antioxidant ca-
pacity of plant foods. These antioxidants also exhibit diverse bio-
logical activities. It seems that these activities are related to their
antioxidant activity and a-amylase and a-glucosidase inhibitory
activity. Solanum xanthocarpum,O. sanctum, and Acacia pennata
can be used in the dietary management of type 2 diabetes
mellitus because of high contents of polyphenolics like, caffeic acid
and p-coumaric acid [25,26]. Polyphenolic compounds, especially
ﬂavonoids, are widely investigated because of their anti-diabetic
properties [27]. Flavonoids are natural polyphenolic molecules
from plants known for their antioxidant, anti-inﬂammatory, and
anti-carcinogenic properties [28]. Flavonoids may be included in
diets as an effective alternative treatment for diabetes; these
substances may also be administered to reduce the risk of
diabetes [29].
Thus, the total phenolic and total ﬂavonoid contents of
different O. tenuiﬂorum leaf extracts were also evaluated [29].
Polyphenolic compounds likely stabilize lipid oxidation and
participate in antioxidant activity [30]. Polyphenolic compounds
also elicit inhibitory effects on mutagenesis and carcinogenesis
in humans; at 1.0 g, these compounds are ingested daily from a
diet rich in fruits and vegetables [27]. Owing to previous result,
the ﬂavonoids have been shown to have an important
antidiabetic activity and are able to affect the regeneration of
pancreatic beta cells in additional phenolic compounds of plants
extracts which have been reported to reduce blood glucose
level [31]. Our results also revealed that the phenolic and
ﬂavonoid contents were respectively the highest in aqueous and
ethyl acetate extracts but were approximately similar to those of
the methanol extract. The phenolic and ﬂavonoid contents also
increased the polarity of solvents, and this ﬁnding is similar to
the observed anti-hyperglycemic activity of the extracts. The
aqueous extract with a high phenolic content and the ethyl
acetate extract with high ﬂavonoid content elicited an anti-
hyperglycemic effect to a less extent than the methanol
extract did. Theﬂuctuation enhanced interaction of hydroxyl and/
or carboxylic groups in polar solvent to promote the dissolution of
phenolics in the solvent [32]. However, the interaction is decreased
by the benzene ring present in the structure, thus restricting the
solubility of phenolic compounds. Plant extracts contain
numerous compounds, whose net observed pharmacological
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antagonistic interactions among these compounds [33]. The
selective and non-predictive interaction of compounds in the
methanol extract of O. tenuiﬂorum leaves may account for its
potent anti-hyperglycemic effect rather than the actual phenolic
and ﬂavonoid contents.
The hypoglycemic and anti-hyperglycemic activities of the
methanol extract and metformin were similar. This ﬁnding may
provide insights into the anti-diabetic mechanism of the meth-
anol extract. Metformin elicits its anti-hyperglycemic effect
primarily by inhibiting the increase in the rates of hepatic
gluconeogenesis and by improving insulin sensitivity through
the stimulation of peripheral glucose uptake in skeletal
muscles and adipose tissues [34]. The methanol extract may
induce its effect via similar mechanisms. However, the rapid
normalization of blood glucose level in the rats treated with the
methanol extract relative to the control rats suggested the
existence of residual b-cells, which must have been sensitized
by compounds, such asﬂavonoids and phenolics in the extract [35].
Thus, O. tenuiﬂorum must be considered as an excellent
candidate for future studies on diabetes mellitus. Further compre-
hensive pharmacological investigations, including active crude
extract fractionation and bioactive compound studies, should be
performed.
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